Cargando…

A10 OVEREXPRESSION OF ASCL2 ALTERS DIFFERENTIATION, CELL CYCLE AND RESISTANCE TO ANTI-CANCER TREATMENT IN ESOPHAGEAL ORGANOIDS

BACKGROUND: The esophagus is in constant contact with the austere environment caused by food and gastric reflux. It is protected by a squamous epithelium which maintenance is provided by a rare subpopulation of basal cells: Keratin 15+ (Krt15+) stem cells. However, little is known about the mechanis...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamilton, M, Mars, Z, Sedeuil, M, Rolland, M, Jean, D, Giroux, V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991315/
http://dx.doi.org/10.1093/jcag/gwac036.010
_version_ 1784902127079915520
author Hamilton, M
Mars, Z
Sedeuil, M
Rolland, M
Jean, D
Giroux, V
author_facet Hamilton, M
Mars, Z
Sedeuil, M
Rolland, M
Jean, D
Giroux, V
author_sort Hamilton, M
collection PubMed
description BACKGROUND: The esophagus is in constant contact with the austere environment caused by food and gastric reflux. It is protected by a squamous epithelium which maintenance is provided by a rare subpopulation of basal cells: Keratin 15+ (Krt15+) stem cells. However, little is known about the mechanisms underlying the expansion and the function of these stem cells. It was shown that the transcription factor ASCL2 is strongly upregulated in Krt15+ cells compared to Krt15- cells. Interestingly, ASCL2 is a gene target of the Wnt/β-catenin pathway, which acts as a regulator of proliferation and maintenance of the stemness state. PURPOSE: The ultimate goal of my research project is to determine the role of ASCL2 in the maintenance of esophageal stem cells. To do so, I will investigate the role of ASCL2 in esophageal epithelial biology. METHOD: Lentiviral infection approach was used to obtain mouse esophageal organoids overexpressing ASCL2 (ASCL2(OE)). Organoid culture, immunostaining (such as IF and H&E), qPCR, WB, mass spectrometry and proliferation assay were used to characterize the effect of ASCL2(OE) on morphology, differentiation, proliferation, self-renewal, and gene expression. RESULT(S): ASCL2(OE) severely altered the morphology of organoids, which were smaller and less differentiated. Defects in differentiation was investigated by IF which showed that some cells expressed both p63 and K13, respectively basal and suprabasal markers. Thus, cells seem to be blocked in an intermediate state of differentiation suggesting a default in cell fate decision. Mass spectrometry analysis confirmed a change in biological processes related to differentiation of keratinocytes and of epithelial cells. We also investigated the role of ASCL2 in self-renewal and observed that organoid formation rate (OFR) was reduced in ASCL2(OE) organoids. Furthermore, proliferation was also reduced in WST-1 and EdU assays. We then observed significant changes in the cell cycle by flow cytometry: there is an increased in the number of cells in G0/G1 and a major decrease in G2/M cells, suggesting a blockade in G1. Interestingly, CDNK2a (p16INK4a), an inhibitor of cell cycle progression, was increased in our mass spectrometry results. Finally, ASCL2 could also play a role in radio and chemoresistance of Krt15+ stem cells, as ASCL2(OE) organoids are less sensitive to radiation and chemotherapy agents than control. CONCLUSION(S): ASCL2 could play a role in orchestrating cell fate decision in the esophageal epithelium as ASCL2(OE) organoids showed alteration in differentiation, proliferation, and cell cycle. PLEASE ACKNOWLEDGE ALL FUNDING AGENCIES BY CHECKING THE APPLICABLE BOXES BELOW: Other PLEASE INDICATE YOUR SOURCE OF FUNDING; NSERC, Canada Research Chairs and CRCHUS scolarship DISCLOSURE OF INTEREST: None Declared
format Online
Article
Text
id pubmed-9991315
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-99913152023-03-08 A10 OVEREXPRESSION OF ASCL2 ALTERS DIFFERENTIATION, CELL CYCLE AND RESISTANCE TO ANTI-CANCER TREATMENT IN ESOPHAGEAL ORGANOIDS Hamilton, M Mars, Z Sedeuil, M Rolland, M Jean, D Giroux, V J Can Assoc Gastroenterol Oral Presentations BACKGROUND: The esophagus is in constant contact with the austere environment caused by food and gastric reflux. It is protected by a squamous epithelium which maintenance is provided by a rare subpopulation of basal cells: Keratin 15+ (Krt15+) stem cells. However, little is known about the mechanisms underlying the expansion and the function of these stem cells. It was shown that the transcription factor ASCL2 is strongly upregulated in Krt15+ cells compared to Krt15- cells. Interestingly, ASCL2 is a gene target of the Wnt/β-catenin pathway, which acts as a regulator of proliferation and maintenance of the stemness state. PURPOSE: The ultimate goal of my research project is to determine the role of ASCL2 in the maintenance of esophageal stem cells. To do so, I will investigate the role of ASCL2 in esophageal epithelial biology. METHOD: Lentiviral infection approach was used to obtain mouse esophageal organoids overexpressing ASCL2 (ASCL2(OE)). Organoid culture, immunostaining (such as IF and H&E), qPCR, WB, mass spectrometry and proliferation assay were used to characterize the effect of ASCL2(OE) on morphology, differentiation, proliferation, self-renewal, and gene expression. RESULT(S): ASCL2(OE) severely altered the morphology of organoids, which were smaller and less differentiated. Defects in differentiation was investigated by IF which showed that some cells expressed both p63 and K13, respectively basal and suprabasal markers. Thus, cells seem to be blocked in an intermediate state of differentiation suggesting a default in cell fate decision. Mass spectrometry analysis confirmed a change in biological processes related to differentiation of keratinocytes and of epithelial cells. We also investigated the role of ASCL2 in self-renewal and observed that organoid formation rate (OFR) was reduced in ASCL2(OE) organoids. Furthermore, proliferation was also reduced in WST-1 and EdU assays. We then observed significant changes in the cell cycle by flow cytometry: there is an increased in the number of cells in G0/G1 and a major decrease in G2/M cells, suggesting a blockade in G1. Interestingly, CDNK2a (p16INK4a), an inhibitor of cell cycle progression, was increased in our mass spectrometry results. Finally, ASCL2 could also play a role in radio and chemoresistance of Krt15+ stem cells, as ASCL2(OE) organoids are less sensitive to radiation and chemotherapy agents than control. CONCLUSION(S): ASCL2 could play a role in orchestrating cell fate decision in the esophageal epithelium as ASCL2(OE) organoids showed alteration in differentiation, proliferation, and cell cycle. PLEASE ACKNOWLEDGE ALL FUNDING AGENCIES BY CHECKING THE APPLICABLE BOXES BELOW: Other PLEASE INDICATE YOUR SOURCE OF FUNDING; NSERC, Canada Research Chairs and CRCHUS scolarship DISCLOSURE OF INTEREST: None Declared Oxford University Press 2023-03-07 /pmc/articles/PMC9991315/ http://dx.doi.org/10.1093/jcag/gwac036.010 Text en ڣ The Author(s) 2023. Published by Oxford University Press on behalf of the Canadian Association of Gastroenterology. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Oral Presentations
Hamilton, M
Mars, Z
Sedeuil, M
Rolland, M
Jean, D
Giroux, V
A10 OVEREXPRESSION OF ASCL2 ALTERS DIFFERENTIATION, CELL CYCLE AND RESISTANCE TO ANTI-CANCER TREATMENT IN ESOPHAGEAL ORGANOIDS
title A10 OVEREXPRESSION OF ASCL2 ALTERS DIFFERENTIATION, CELL CYCLE AND RESISTANCE TO ANTI-CANCER TREATMENT IN ESOPHAGEAL ORGANOIDS
title_full A10 OVEREXPRESSION OF ASCL2 ALTERS DIFFERENTIATION, CELL CYCLE AND RESISTANCE TO ANTI-CANCER TREATMENT IN ESOPHAGEAL ORGANOIDS
title_fullStr A10 OVEREXPRESSION OF ASCL2 ALTERS DIFFERENTIATION, CELL CYCLE AND RESISTANCE TO ANTI-CANCER TREATMENT IN ESOPHAGEAL ORGANOIDS
title_full_unstemmed A10 OVEREXPRESSION OF ASCL2 ALTERS DIFFERENTIATION, CELL CYCLE AND RESISTANCE TO ANTI-CANCER TREATMENT IN ESOPHAGEAL ORGANOIDS
title_short A10 OVEREXPRESSION OF ASCL2 ALTERS DIFFERENTIATION, CELL CYCLE AND RESISTANCE TO ANTI-CANCER TREATMENT IN ESOPHAGEAL ORGANOIDS
title_sort a10 overexpression of ascl2 alters differentiation, cell cycle and resistance to anti-cancer treatment in esophageal organoids
topic Oral Presentations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991315/
http://dx.doi.org/10.1093/jcag/gwac036.010
work_keys_str_mv AT hamiltonm a10overexpressionofascl2altersdifferentiationcellcycleandresistancetoanticancertreatmentinesophagealorganoids
AT marsz a10overexpressionofascl2altersdifferentiationcellcycleandresistancetoanticancertreatmentinesophagealorganoids
AT sedeuilm a10overexpressionofascl2altersdifferentiationcellcycleandresistancetoanticancertreatmentinesophagealorganoids
AT rollandm a10overexpressionofascl2altersdifferentiationcellcycleandresistancetoanticancertreatmentinesophagealorganoids
AT jeand a10overexpressionofascl2altersdifferentiationcellcycleandresistancetoanticancertreatmentinesophagealorganoids
AT girouxv a10overexpressionofascl2altersdifferentiationcellcycleandresistancetoanticancertreatmentinesophagealorganoids